Ignite Creation Date:
2025-12-24 @ 2:32 PM
Ignite Modification Date:
2026-05-15 @ 4:29 PM
Study NCT ID:
NCT02577159
Status:
UNKNOWN
Last Update Posted:
2018-08-29
First Post:
2015-08-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dapagliflozin on Hyperlipidemia and Insulin Resistance in Type 2 Diabetic Patients (DAPHNIS Study)
Sponsor:
Osaka University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
DAPHNIS
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None